No JH - Search Results

1

Infectivity and Drug Susceptibility Profiling of Different Leishmania-Host Cell Combinations.

Baek KH, Piel L, Rosazza T, Prina E, Späth GF, No JH. Baek KH, et al. Among authors: no jh. Pathogens. 2020 May 20;9(5):393. doi: 10.3390/pathogens9050393. Pathogens. 2020. PMID: 32443883 Free PMC article.

2

From Drug Screening to Target Deconvolution: a Target-Based Drug Discovery Pipeline Using Leishmania Casein Kinase 1 Isoform 2 To Identify Compounds with Antileishmanial Activity.

Durieu E, Prina E, Leclercq O, Oumata N, Gaboriaud-Kolar N, Vougogiannopoulou K, Aulner N, Defontaine A, No JH, Ruchaud S, Skaltsounis AL, Galons H, Späth GF, Meijer L, Rachidi N. Durieu E, et al. Among authors: no jh. Antimicrob Agents Chemother. 2016 Apr 22;60(5):2822-33. doi: 10.1128/AAC.00021-16. Print 2016 May. Antimicrob Agents Chemother. 2016. PMID: 26902771 Free PMC article.

3

In Vitro and in Vivo Activity of mTOR Kinase and PI3K Inhibitors Against Leishmania donovani and Trypanosoma brucei.

Phan TN, Baek KH, Lee N, Byun SY, Shum D, No JH. Phan TN, et al. Among authors: no jh. Molecules. 2020 Apr 23;25(8):1980. doi: 10.3390/molecules25081980. Molecules. 2020. PMID: 32340370 Free PMC article.

4

Discovery of Leishmania donovani topoisomerase IB selective inhibitors by targeting protein-protein interactions between the large and small subunits.

Lee H, Baek KH, Phan TN, Park IS, Lee S, Kim J, No JH. Lee H, et al. Among authors: no jh. Biochem Biophys Res Commun. 2021 Sep 10;569:193-198. doi: 10.1016/j.bbrc.2021.07.019. Epub 2021 Jul 10. Biochem Biophys Res Commun. 2021. PMID: 34256188

5

In Vivo Efficacy of SQ109 against Leishmania donovani, Trypanosoma spp. and Toxoplasma gondii and In Vitro Activity of SQ109 Metabolites.

Baek KH, Phan TN, Malwal SR, Lee H, Li ZH, Moreno SNJ, Oldfield E, No JH. Baek KH, et al. Among authors: no jh. Biomedicines. 2022 Mar 14;10(3):670. doi: 10.3390/biomedicines10030670. Biomedicines. 2022. PMID: 35327472 Free PMC article.

6

Synthesis and Testing of Analogs of the Tuberculosis Drug Candidate SQ109 against Bacteria and Protozoa: Identification of Lead Compounds against Mycobacterium abscessus and Malaria Parasites.

Stampolaki M, Malwal SR, Alvarez-Cabrera N, Gao Z, Moniruzzaman M, Babii SO, Naziris N, Rey-Cibati A, Valladares-Delgado M, Turcu AL, Baek KH, Phan TN, Lee H, Alcaraz M, Watson S, van der Watt M, Coertzen D, Efstathiou N, Chountoulesi M, Shoen CM, Papanastasiou IP, Brea J, Cynamon MH, Birkholtz LM, Kremer L, No JH, Vázquez S, Benaim G, Demetzos C, Zgurskaya HI, Dick T, Oldfield E, Kolocouris AD. Stampolaki M, et al. Among authors: no jh. ACS Infect Dis. 2023 Feb 10;9(2):342-364. doi: 10.1021/acsinfecdis.2c00537. Epub 2023 Jan 27. ACS Infect Dis. 2023. PMID: 36706233 Free PMC article.

7

Phenolic Constituents of Medicinal Plants with Activity against Trypanosoma brucei.

Sun YN, No JH, Lee GY, Li W, Yang SY, Yang G, Schmidt TJ, Kang JS, Kim YH. Sun YN, et al. Among authors: no jh. Molecules. 2016 Apr 12;21(4):480. doi: 10.3390/molecules21040480. Molecules. 2016. PMID: 27077842 Free PMC article.

8

Evaluation of Parameters Impacting Drug Susceptibility in Intracellular Trypanosoma cruzi Assay Protocols.

Yang G, Lee N, Ioset JR, No JH. Yang G, et al. Among authors: no jh. SLAS Discov. 2017 Feb;22(2):125-134. doi: 10.1177/1087057116673796. Epub 2016 Oct 13. SLAS Discov. 2017. PMID: 27729503 Free PMC article.

9

Comparative study of different forms of Jellein antimicrobial peptide on Leishmania parasite.

Zahedifard F, Lee H, No JH, Salimi M, Seyed N, Asoodeh A, Rafati S. Zahedifard F, et al. Among authors: no jh. Exp Parasitol. 2020 Feb;209:107823. doi: 10.1016/j.exppara.2019.107823. Epub 2019 Dec 17. Exp Parasitol. 2020. PMID: 31862270

10

Design, Rational Repurposing, Synthesis, In Vitro Evaluation, Homology Modeling and In Silico Study of Sulfuretin Analogs as Potential Antileishmanial Hit Compounds.

Hassan AHE, Phan TN, Choi Y, Moon S, No JH, Lee YS. Hassan AHE, et al. Among authors: no jh. Pharmaceuticals (Basel). 2022 Aug 26;15(9):1058. doi: 10.3390/ph15091058. Pharmaceuticals (Basel). 2022. PMID: 36145279 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

177 results

Search Page